Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.34 | N/A |
| PEG Ratio (TTM) | -9.25 | N/A |
| P/S Ratio (TTM) | 2.11 | N/A |
| P/B Ratio (TTM) | 0.93 | N/A |
| P/FCF Ratio (TTM) | 10.96 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.72 | N/A |
| Price to 5YR AVG FCF Ratio | 10.48 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.66% | N/A |
| ROE (TTM) | 5.52% | N/A |
| Net Profit Margin (TTM) | 12.18% | N/A |
| ROIC 5YR AVG | 8.72% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 130.40% | 27.56% | 10.52% |
| Revenue | 10.01% | 51.93% | 34.38% |
| Net Income | 131.92% | 67.00% | 35.96% |
| Cash Flow | 145.76% | 63.20% | 32.80% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.16 | N/A |
| Quick Ratio (TTM) | 0.16 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 0.42 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 2.32 | N/A |
| Shares Outstanding Growth 5YR AVG | 24.50% | N/A |